Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 58 min ago
Peer-reviewedLicence not statedJournal of Managed Care & Specialty Pharmacy

Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications

  • Lucille M. Abrams1
  • Kylee Funk2
  • Joel F. Farley2
  1. 1Minnesota Department of Health, St Paul
  2. 2College of Pharmacy, University of Minnesota, Minneapolis
Read full textDOICite

Related

  1. Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience.
    Mariá Simas D'Aquino, Roberto Moreira Amorim Filho, Gustavo Moreira Amorim
    Acta dermato-venereologicaPeer-reviewedCC BY-NCFull textImmunologyEurope PMCPMC
  2. Cophylogeny simulators are not interchangeable: similarities, differences and structural biases in synthetic host-symbiont
    G. Di Palma, C. Matias, B. Sinaimeri
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  3. Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation
    Ting Wang, Jenny Zheng, Po‐Hung Hsieh +3
    Clinical Pharmacology and TherapeuticsPeer-reviewedPublic domainFull textImmunologyPMC
  4. N-GLYcanyzer monitoring of a microperfusion process reveals critical parameters' impact on Trastuzumab biosimilar N-glycoform time evolution
    A. Narvekar, M. Harrison, R. Thakur +4
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  5. Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union
    Rakesh Aithal, Olivia M. Majedi, Diane McCarthy +2
    BioDrugsPeer-reviewedCC BY-NCFull text6 citedImmunologyOpenAlex

Cite

BibTeXRIS
BibTeX
@article{abrams2026comparing,
  title = {{Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications}},
  author = {Lucille M. Abrams and Kylee Funk and Joel F. Farley},
  journal = {Journal of Managed Care \& Specialty Pharmacy},
  year = {2026},
  month = nov,
  doi = {10.18553/jmcp.2026.32.11.1339},
  url = {https://doi.org/10.18553/jmcp.2026.32.11.1339},
}
RIS
TY  - JOUR
TI  - Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications
AU  - Lucille M. Abrams
AU  - Kylee Funk
AU  - Joel F. Farley
PY  - 2026
DA  - 2026/11/01
JO  - Journal of Managed Care & Specialty Pharmacy
DO  - 10.18553/jmcp.2026.32.11.1339
UR  - https://doi.org/10.18553/jmcp.2026.32.11.1339
SN  - 2376-0540
SN  - 2376-1032
ER  -